Morningstar, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$474.50M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MORN stock price vs MKTX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MKTX's multiple
Needs MKTX P/E.
Implied fair value · at MORN's multiple
Needs MORN P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MORNINGSTAR, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
MARKETAXESS HOLDINGS INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
FACTSET RESEARCH SYSTEMS INC
MORN vs FDS
MOODYS CORP /DE/
MORN vs MCO
BROADRIDGE FINANCIAL SOLUTIONS, INC.
MORN vs BR
MSCI Inc.
MORN vs MSCI
S&P Global Inc.
MORN vs SPGI
NASDAQ, INC.
MORN vs NDAQ
Tradeweb Markets Inc.
MORN vs TW
Virtu Financial, Inc.
MORN vs VIRT
CME GROUP INC.
MORN vs CME
FISERV INC
MORN vs FI
GLOBAL PAYMENTS INC
MORN vs GPN
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe MORN can sustain its faster revenue growth and preserve its strong gross margin while improving operating leverage, then hold or accumulate on weakness; otherwise, the P/E-based downside and MKTX’s superior profitability suggest limited relative upside from here.
MORN’s current price of $175.22 is below the P/E implied value of $161.52? Actually the stated implied price suggests a 7.8% downside versus the current price, indicating the stock is modestly rich on this framework. At the same time, the share price sits above the low end of the historical band and below the midpoint of MKTX-implied range, which makes the valuation picture mixed rather than clearly cheap or expensive.
Supporting Metrics